Found: 5
Select item for more details and to access through your institution.
The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies.
- Published in:
- European Journal of Endocrinology, 2008, v. 159, n. 3, p. 301, doi. 10.1530/EJE-08-0062
- By:
- Publication type:
- Article
A new functional parameter measured at the time of ablation that can be used to predict differentiated thyroid cancer recurrence during follow-up.
- Published in:
- European Journal of Endocrinology, 2007, v. 156, n. 1, p. 41, doi. 10.1530/eje.1.02322
- By:
- Publication type:
- Article
The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.
- Published in:
- European Journal of Endocrinology, 2006, v. 155, n. 6, p. 801, doi. 10.1530/eje.1.02300
- By:
- Publication type:
- Article
No survival difference after successful <sup>131</sup>I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 2, p. 276, doi. 10.1007/s00259-009-1315-6
- By:
- Publication type:
- Article
Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2003, v. 129, n. 5, p. 287, doi. 10.1007/s00432-003-0435-9
- By:
- Publication type:
- Article